one tim purche.
We know the game and are buying today and tomoroow and Friday !
Natural Killer Cells in your own immune system !
Oragenics’ new lead clinical candidate achieved a 100% survival rate throughout the entire study in contrast to a 33% survival rate for the vancomycin (current standard of care) positive control. There was a 0% survival rate for the placebo control group.
Yes that includes all warrants. This is dirt cheap. $10 gives just a 1.6m market cap not close to the billions other biotech with faulty alzheiners have.